Kennett Square, Pennsylvania
United States
147
2025-12-25
The entities that hold a legal rights for patent applications filed by inventor Combs Andrew P.:
Andrew P. Combs from Kennett Square, US has applied for patents for these inventions. The list has both pending applications and granted patents:
AMINOPYRAZINE DERIVATIVES AS PI3K-y INHIBITORS
#2 | 2025-10-23HETEROCYCLYLAMINES AS PI3K INHIBITORS
#3 | 2025-10-09AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS
#4 | 2025-09-18USE OF PYRAZOLOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3K-DELTA RELATED DISORDERS
#5 | 2025-07-31CRYSTALLINE FORMS OF A PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITOR
#6 | 2025-05-081H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS
#7 | 2025-04-24BICYCLIC HETEROARYLAMINOALKYL PHENYL DERIVATIVES AS PI3K INHIBITORS
#8 | 2024-12-05AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS
#9 | 2024-07-11TERTIARY ALCOHOLS AS PI3K-y INHIBITORS
#10 | 2024-07-04Heterocyclylamines as PI3K inhibitors
#11 | 2024-05-301,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- Dioxygenase
#12 | 2024-04-18MUTANT PI3K-ALPHA INHIBITORS AND THEIR USE AS PHARMACEUTICALS
#13 | 2024-01-041H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c] pyridin-7(6H)-ones as inhibitors of BET proteins
#14 | 2023-08-24Heterocycle CDK Inhibitors And Their Use Thereof
#15 | 2023-04-20Heterocyclylamines as PI3K inhibitors
#16 | 2023-01-12HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS
#17 | 2022-12-29AMINOPYRAZINE DERIVATIVES AS PI3K-y INHIBITORS
#18 | 2022-10-27SUBSTITUTED HETEROCYCLIC DERIVATIVES AS PI3K INHIBITORS
#19 | 2022-10-201,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- Dioxygenase
#20 | 2022-08-11Substituted imidazo[2,1-f][1,2,4]triazines as PI3K-gamma inhibitors
#21 | 2022-07-21Pyridine and pyridimine compounds as PI3K-gamma inhibitors
#22 | 2022-07-07Tertiary alcohols as PI3K-γ inhibitors
#23 | 2022-07-07Aminopyrazine diol compounds as PI3K-γ inhibitors
#24 | 2022-06-09Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
#25 | 2022-04-21USE OF PYRAZOLOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3K-DELTA RELATED DISORDERS
#26 | 2022-04-14Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor
#27 | 2022-04-07Use of pyrazolopyrimidine derivatives for the treatment of PI3K-δ related disorders
#28 | 2021-12-23Heterocyclic derivatives as PI3K inhibitors
#29 | 2021-10-28USE OF PYRAZOLOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3K-DELTA RELATED DISORDERS
#30 | 2021-09-301H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins
#31 | 2021-08-19Pyrimidinones as PI3K inhibitors
#32 | 2021-06-24Tricyclic heterocycles as BET protein inhibitors
#33 | 2021-02-041,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
#34 | 2020-12-10Tertiary alcohols as PI3K-γ inhibitors
#35 | 2020-12-031H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins
#36 | 2020-10-29AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS
#37 | 2020-10-223-(5-amino-pyrazin-2-yl)-benzenesulfonamide derivatives and related compounds as PI3K-gamma kinase inhibitors
#38 | 2020-10-15Heterocyclylamines as PI3K inhibitors
#39 | 2020-08-06Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
#40 | 2020-05-14Heterocyclic derivatives as PI3K inhibitors
#41 | 2020-05-14Heterocyclic derivatives as PI3K inhibitors
#42 | 2020-05-14Substituted heterocyclic derivatives as PI3K inhibitors
#43 | 2020-04-30Tricyclic heterocycles as BET protein inhibitors
#44 | 2020-04-23Pyrimidinones as PI3K inhibitors
#45 | 2020-04-02Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors
#46 | 2020-03-05Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor
#47 | 2020-02-131H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins
#48 | 2020-01-30Heterocyclic compounds as PI3K-y inhibitors
#49 | 2020-01-02Aminopyrazine derivatives as PI3K-γ inhibitors
#50 | 2019-11-28Pyridine and pyridimine compounds as PI3K-gamma inhibitors
#51 | 2019-10-03Heterocyclylamines as PI3K inhibitors
#52 | 2019-10-031,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
#53 | 2019-09-12Aminopyrazine diol compounds as PI3K-γ inhibitors
#54 | 2019-08-01Tricyclic heterocycles as BET protein inhibitors
#55 | 2019-07-11Modulators of indoleamine 2,3-dioxygenase and methods of using the same
#56 | 2019-05-23Tertiary alcohols as PI3K-γ inhibitors
#57 | 2019-05-09Heterocyclylamines as PI3K inhibitors
#58 | 2019-04-25Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors
#59 | 2019-03-21Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
#60 | 2019-02-28Heterocyclic compounds as PI3K-γ inhibitors
#61 | 2019-02-28Aza-heteroaryl compounds as PI3K-gamma inhibitors
#62 | 2019-02-07USE OF PYRAZOLOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3K-DELTA RELATED DISORDERS
#63 | 2019-01-03Bicyclic azaheterocyclobenzylamines as PI3K inhibitors
#64 | 2018-12-20Pyrimidinones as PI3K inhibitors
#65 | 2018-12-06Tricyclic heterocycles as BET protein inhibitors
#66 | 2018-11-011H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins
#67 | 2018-08-09Tricyclic heterocycles as bet protein inhibitors
#68 | 2018-06-281,2,5-Oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
#69 | 2018-02-01Modulators of indoleamine 2,3-dioxygenase and methods of using the same
#70 | 2018-01-11Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-γ inhibitors
#71 | 2017-12-07Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b] pyrimidin-5-yl-amines as Janus kinase inhibitors
#72 | 2017-12-071,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
#73 | 2017-11-30Heterocyclylamines as PI3K inhibitors
#74 | 2017-08-17Aza-heteroaryl compounds as PI3K-gamma inhibitors
#75 | 2017-08-03Tricyclic heterocycles as BET protein inhibitors
#76 | 2017-07-27Tricyclic heterocycles as BET protein inhibitors
#77 | 2017-07-06PYRIDINE AND PYRIDIMINE COMPOUNDS AS PI3K-GAMMA INHIBITORS
#78 | 2017-06-08Tricyclic heterocycles as bet protein inhibitors
#79 | 2017-06-08N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
#80 | 2017-06-081H-pyrrolo[2,3,c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins
#81 | 2017-05-11Heterocyclic compounds as PI3K-γ inhibitors
#82 | 2017-02-23Pyrimidinones as PI3K inhibitors
#83 | 2017-01-19Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors
#84 | 2016-09-15Bicyclic azaheterocyclobenzylamines as PI3K inhibitors
#85 | 2016-08-11Aza-heteroaryl compounds as PI3K-gamma inhibitors
#86 | 2016-08-041,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
#87 | 2016-07-28Bicyclic heterocycles as bet protein inhibitors
#88 | 2016-06-09Tricyclic heterocycles as BET protein inhibitors
#89 | 2016-03-17Tricyclic heterocycles as BET protein inhibitors
#90 | 2016-02-18Tricyclic heterocycles as BET protein inhibitors
#91 | 2016-01-28Heterocyclylamines as PI3K inhibitors
#92 | 2016-01-28Heterocyclylamines as PI3K inhibitors
#93 | 2015-12-17Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
#94 | 2015-11-05Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors
#95 | 2015-10-291H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins
#96 | 2015-10-08N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
#97 | 2015-07-091,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
#98 | 2015-05-28Bicyclic heterocycles as BET protein inhibitors
#99 | 2015-05-28BICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS
#100 | 2015-05-28Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors
128957 ⎘